However, these medications are not suitable for everyone
The denominator (total users) isn't publicly available, which means you can't calculate a per-user risk from these figures
Participants who had adapted to their maintenance doses early in the study often reported fewer side effects over time, supporting the concept that Retatrutides tolerability profile improves with continued weekly dosing
Injection details: Record the date, time, dose, injection site, and lot number from your vial
However, because Retatrutide remains a pre-approval research compound in the UK, supply must be correctly positioned for laboratory use only
( Further reading: Where to buy retatrutide in the UK) In the TRIUMPH-1 Phase 3 trial, the most common retatrutide side effects were nausea, diarrhoea, constipation and vomiting